Recordati Industria Chimica e Farmaceutica S.p.A. (REC)
MTA
52.20
-0.40 (-0.76%)
Closed
Oct 5, 2026
Day's Range
52.2052.60
52 wk Range
43.7654.45
Financial Statements - REC - Recordati Industria Chimica e Farmaceutica S.p.A.
Revenue
2.61B▲ 11.8%
Net Income
443.62M▲ 6.5%Net Margin 16.9%
EBITDA
939.26M▲ 14.1%
Free Cash Flow
511.77M▲ 282.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.61B | 2.34B | 2.08B | 1.85B | 1.58B | 1.44B |
| Cost of Goods | 830.70M | 741.28M | 659.70M | 566.73M | 427.72M | 406.83M |
| Gross Profit | 1.78B | 1.60B | 1.42B | 1.28B | 1.15B | 1.04B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 719.73M | 659.87M | 565.76M | 494.31M | 505.32M | 473.94M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 581.27M | 547.18M | 491.03M | 401.43M | 463.34M | 455.65M |
| Income Tax | 137.65M | 130.67M | 101.82M | 89.09M | 77.38M | 100.62M |
| Net Income | 443.62M | 416.50M | 389.21M | 312.33M | 385.96M | 355.02M |
| EPS Basic | 2.159 | 2.019 | 1.893 | 1.519 | 1.874 | 1.725 |
| EPS Diluted | 2.121 | 1.992 | 1.861 | 1.494 | 1.846 | 1.698 |
| Basic Shares Outstanding | 205.47M | 206.29M | 205.63M | 205.58M | 206.01M | 205.75M |
| Diluted Shares Outstanding | 205.47M | 206.29M | 205.63M | 205.58M | 206.01M | 205.75M |
| Ebit | 680.56M | 628.34M | 565.49M | 433.59M | 480.76M | 473.15M |
| Ebitda | 939.26M | 823.13M | 712.44M | 614.61M | 596.31M | 573.44M |
| Net Income Continuous Operations | 443.62M | 416.50M | 389.21M | 312.33M | 385.96M | 355.02M |
| Minority Interests | 0 | 0 | 0 | 0 | 0 | -43K |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
